Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of huntington disease

Journal of Neuropathology and Experimental Neurology

Volumn 67, Issue 12, 2008, Pages 1159-1165

  Schwab, Claudia ^a   Arai, Tetsuaki ^b   Hasegawa, Masato ^c   Yu, Sheng ^a   McGeer, Patrick L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Department of Psychogeriatrics ^*

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Huntingtin; Intracellular inclusions; Phosphorylation dependent TDP 43 antibodies; TDP 43; Ubiquitin

Indexed keywords

HUNTINGTIN; PROTEIN ANTIBODY; TAR DNA BINDING PROTEIN; UBIQUITIN; BIOLOGICAL MARKER; DNA BINDING PROTEIN; HD PROTEIN, HUMAN; NERVE PROTEIN; NUCLEAR PROTEIN; PROTEIN TDP-43; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BRAIN TISSUE; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; HUNTINGTON CHOREA; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SPACE; MALE; NEURITE; NEUROAXONAL DYSTROPHY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; ANTIBODY SPECIFICITY; BRAIN; CELL INCLUSION; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; ULTRASTRUCTURE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODY SPECIFICITY; BIOLOGICAL MARKERS; BRAIN; CELL NUCLEUS; DNA-BINDING PROTEINS; FEMALE; HUMANS; HUNTINGTON DISEASE; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURITES; NEURONS; NUCLEAR PROTEINS; PHOSPHORYLATION; UBIQUITIN;

EID: 58149398638     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31818e8951     Document Type: Article

References (38)

1. Arai T, Hasegawa M, Akiyama H, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006;351:602-611
2. Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130-133
3. Ou SH, Wu F, Harrich D, et al. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 1995;69:3584-3596
4. Buratti E, Dork T, Zuccato E, et al. Nuclear factor TDP-43 and SRproteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 2001;20:1774-84
5. Mackenzie IR, Baborie A, Pickering-Brown S, et al. Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: Classification and relation to clinical phenotype. Acta Neuropathol 2006;112:539-549
6. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007;114:5-22
7. Cairns NJ, Neumann M, Bigio EH, et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 2007;171:227-240 (Pubitemid 47342406)
8. Dickson DW, Josephs KA, Amador-Ortiz C, et al. TDP-43 in differential diagnosis of motor neuron disorders. Acta Neuropathol 2007;114:71-79
9. Davidson Y, Kelley T, Mackenzie IR, et al. Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNAbinding protein, TDP-43. Acta Neuropathol 2007;113:521-533
10. Amador-Ortiz C, Lin WL, Ahmed Z, et al. TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 2007;61: 435-445
11. Higashi S, Iseki E, Yamamoto R, et al. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res 2007;1184:284-294
12. Geser F, Winton MJ, Kwong LK, et al. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Acta Neuropathol 2008;115:133-145 (Pubitemid 350238671)
13. Hasegawa M, Arai T, Akiyama H, et al. TDP-43 is deposited in the Guam parkinsonism-dementia complex brains. Brain 2007;130:1386-1394
14. Nakashima-Yasuda H, Uryu K, Robinson J, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 2007;114:221-229
15. Uryu K, Nakashima-Yasuda H, Forman MS, et al. Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol 2008;67:555-564
16. Graham RK, Deng Y, Slow EJ, et al. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 2006;125:1179-1191
17. Warby SC, Doty CN, Graham RK, et al. Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus. Hum Mol Genet 2008;17:2390-2404
18. DiFiglia M, Sapp E, Chase KO, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997;277:1990-1993
19. Maat-Schieman M, Roos R, Losekoot M, et al. Neuronal intranuclear and neuropil inclusions for pathological assessment of Huntington's disease. Brain Pathol 2007;17:31-37
20. Maat-Schieman ML, Dorsman JC, Smoor MA, et al. Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain. J Neuropathol Exp Neurol 1999;58:129-137
21. Sapp E, Penney J, Young A, et al. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease. J Neuropathol Exp Neurol 1999;58:165-173
22. Sapp E, Schwarz C, Chase K, et al. Huntingtin localization in brains of normal and Huntington's disease patients. Ann Neurol 1997;42: 604-12
23. Hasegawa M, Arai T, Nonaka T, et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol 2008;64:60-70
24. Schnell SA, Staines WA, Wessendorf MW. Reduction of lipofuscin-like autofluorescence in fluorescently labeled tissue. J Histochem Cytochem 1999;47:719-730
25. SieradzanKA,MechanAO,Jones L,et al. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein. Exp Neurol 1999;156:92-99
26. Mackenzie IR, Bigio EH, Ince PG, et al. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 2007;61:427-434
27. Tan CF, Eguchi H, Tagawa A, et al. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol 2007;113:535-542
28. Marui W, Iseki E, Nakai T, et al. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies. J Neurol Sci 2002;195:153-159
29. Obi K, Akiyama H, Kondo H, et al. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies. Exp Neurol 2008;210: 409-420
30. Ferrer I, Gomez-Isla T, Puig B, et al. Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies. Curr Alzheimer Res 2005;2:3-18
31. Luna-Munoz J, Chavez-Macias L, Garcia-Sierra F, et al. Earliest stages of tau conformational changes are related to the appearance of a sequence of specific phospho-dependent tau epitopes in Alzheimer's disease. J Alzheimers Dis 2007;12:365-375
32. Cook C, Zhang YJ, Xu YF, et al. TDP-43 in neurodegenerative disorders. Expert Opin Biol Ther 2008;8:969-978
33. Wellington CL, Ellerby LM, Gutekunst CA, et al. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J Neurosci 2002;22:7862-7872
34. Mondragon-Rodriguez S, Basurto-Islas G, Santa-Maria I, et al. Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease. Int J Exp Pathol 2008;89:81-90
35. Igaz LM, Kwong LK, Xu Y, et al. Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol 2008;173:182-94
36. Rohn TT. Caspase-cleaved TAR DNA-binding protein-43 is a major pathological finding in Alzheimer's disease. Brain Res 2008;1228: 189-98
37. Imarisio S, Carmichael J, Korolchuk V, et al. Huntington's disease: From pathology and genetics to potential therapies. Biochem J 2008;412: 191-209
38. Strong MJ, Volkening K, Hammond R, et al. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci 2007;35:320-327 (Pubitemid 46843567)